Loading...
Anti-ROS1 Recombinant Antibody Products
Loading...Anti-ROS1 Products
- Mouse Anti-ROS1 Recombinant Antibody (MOB-0237F) (MOB-0237F)
-
- Species Reactivity: Human, Mouse
- Type: Mouse IgG
- Application: IHC-P, IF
-
- Species Reactivity: Human
- Type: Mouse IgG2a
- Application: IHC-P
-
- Species Reactivity: Human
- Application: FC, ICC, IF, IHC-Fr, IHC-P, IP, WB
-
- Derivation: Phage display library screening
- Species Reactivity: Rat, Human
- Type: IgG
- Application: WB
-
- Antibody Host: Mouse
- Antibody Reactivity: Human
- Anti-ROS1 Immunohistochemistry Kit (VS-0525-XY6182)
-
- Species Reactivity: Human
- Target: ROS1
- Application: IHC
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs offers a comprehensive suite of recombinant antibodies targeting ROS1, engineered through rigorous molecular design processes to ensure high specificity and binding affinity across standardized methodologies, including western blotting, ELISA, and flow cytometry. Verified for functional consistency, these antibodies are meant to speed up treatment development processes by allowing exact probing of ROS1 signaling pathways. These instruments have great promise to propel translational research in ROS1-driven oncogenesis forward by simplifying the path of targeted treatments towards clinical use.
ROS1: An Investigational Therapeutic Target for Malignant Tumors
ROS1, a proto-oncogene encoding a transmembrane receptor tyrosine kinase of the insulin receptor family, drives oncogenic signaling through structural alterations such as mutations or chromosomal rearrangements that constitutively activate its kinase domain. These dysregulated events promote tumorigenesis across multiple malignancies. While pharmacological targeting of ROS1 kinase activity has yielded clinically approved inhibitors, the mechanisms governing treatment resistance and dose-limiting toxicities remain poorly characterized. A comprehensive dissection of ROS1’s signaling networks and context-dependent roles in oncogenesis is therefore imperative to advance therapeutic strategies.
Alternative Names
Proto-oncogene tyrosine-protein kinase ROS; MCF3; ROS; c-ros-1; ROS proto-oncogene 1; receptor tyrosine kinase.
Background
This proto-oncogene, highly-expressed in a variety of tumor cell lines, belongs to the sevenless subfamily of tyrosine kinase insulin receptor genes. The protein encoded by this gene is a type I integral membrane protein with tyrosine kinase activity. The protein may function as a growth or differentiation factor receptor. [provided by RefSeq, Jul 2008]
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins
Intracellular, Membrane (different isoforms)
Cell type enriched (Alveolar cells type 2)
Not detected in immune cells
Group enriched (GAMG, HSkMC, hTCEpi, LHCN-M2)
Interacts with PTPN6 (via SH2 1 domain); the interaction is direct and promotes ROS1 dephosphorylation (By similarity). Interacts with PTPN11; may activate the PI3 kinase-mTOR signaling pathway. Interacts with VAV3; constitutive interaction mediating VAV3 phosphorylation.
Kinase, Receptor, Transferase, Tyrosine-protein kinase
Anti-ROS1 rAb Products
Creative Biolabs' anti-ROS1 recombinant antibodies are precision-engineered for enhanced target engagement and specificity, featuring multifunctional molecular architectures compatible with applications ranging from immune response profiling to oncogenic mechanism elucidation and therapeutic candidate screening. Rigorous bioprocessing protocols, complemented by multi-tiered analytical validation (e.g., structural epitope characterization and ligand interaction analyses), ensure batch-to-batch reproducibility. This methodological integration of protein engineering with standardized production processes yields biologics with optimized binding kinetics and discriminatory selectivity—attributes essential for mechanistic studies and therapeutic innovation.
Table 1. Featured anti-ROS1 recombinant antibody products at Creative Biolabs.
| Cat. No. | Product Name | Target Species | Host Species | Applications |
| MOB-1052CT | Recombinant Mouse anti-Human ROS1 Monoclonal antibody (5-7H) | Human | Mouse | FC, ICC/IF, IHC-Fr, IHC-P, IP, WB |
| MOR-3098 | Hi-Affi™ Recombinant Rabbit Anti-ROS1 Monoclonal Antibody (DS3098AB) | Rat, Human | Rabbit IgG | WB |
| VS3-FY1278 | Recombinant Mouse Anti-ROS1 Antibody (clone 4D9-6A7-10G9) | Human | Mouse IgG2a | IHC-P |
Creative Quality Control
Creative Biolabs' recombinant anti-ROS1 antibodies show great antigen selectivity and binding kinetics engineered by a multiphase quality assurance system including process optimization. Their strong performance is confirmed by thorough functional characterisation across orthogonal assay methods supplemented with batch-to-batch repeatability confirmation by multimodal analytics.
Fig.1 IHC-P analysis of anti-ROS1 antibody
(Cat# VS3-FY1278, Creative Biolabs).
Customer Reviews
Mouse Anti-ROS1 Recombinant Antibody (MOB-0237F) (MOB-0237F)
Recombinant Mouse anti-Human ROS1 Monoclonal antibody (5-7H) (MOB-1052CT)
Recombinant Mouse anti-Human ROS1 Monoclonal antibody (5-7H) (MOB-1052CT)
rAb Production
Creative Biolabs offers researchers all across the globe a consistent and reliable supply of premium anti-ROS1 recombinant antibodies as a trusted worldwide partner. Our painstakingly created and verified antibodies guarantee exceptional quality and performance throughout a wide spectrum of research uses by use of modern recombinant technologies. Our commitment is in accelerating scientific progress by providing researchers with dependable reagents necessary to investigate the complexities of ROS1 signaling under several biological contexts.
Featured Anti-ROS1 Recombinant Antibody Production Platforms
Fig.2 Milligram-scale anti-ROS1 recombinant antibody production.
Fig.3 Gram-scale anti-ROS1 recombinant antibody production.
rAb Modalities
Creative Biolabs provides premium, customized anti-ROS1 recombinant antibodies that are designed to address unique research requirements. These antibodies are carefully made to fit the particular requirements of research communities in local, national, and worldwide settings and come in many forms.
Fig.4 Full-length anti-ROS1 recombinant antibody production and modalities.
ROS1-Targeted Drug Information
Table 2. Public drug targeting ROS1.
| Company | Research phase | Classification | Condition |
| Pfizer (Originator) | Preclinical |
Carbon-Radiolabeled Products Nuclear Imaging Agents |
Diagnostics |
| Endotarget (Originator) | Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
| Endotarget (Originator) | Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
| Nuvalent (Originator) | Biological Testing | Deuterated Compounds | Cancer |
| Nuvalent (Originator) | Biological Testing | Deuterated Compounds | Cancer |
| Nuvalent (Originator) | Biological Testing | Deuterated Compounds | Cancer |
| Nuvalent (Originator) | Biological Testing | Deuterated Compounds | Cancer |
| Nuvalent (Originator) | Biological Testing | Deuterated Compounds | Cancer |
| Nuvalent (Originator) | Biological Testing | Deuterated Compounds | Cancer |
| Nuvalent (Originator) | Biological Testing | Deuterated Compounds | Cancer |
| Jing Medicine (Originator) | Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
| Jing Medicine (Originator) | Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
| Jing Medicine (Originator) | Biological Testing | PROTACs (Proteolysis Targeting Chimeras) | Cancer |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Leveraging a wealth of knowledge in antibody development and production, Creative Biolabs provides ROS1 recombinant antibodies that consistently yield exceptional outcomes across a variety of research applications. We are committed to the quality and reliability of our antibodies and encourage researchers exploring the importance of ROS1 to reach out for tailored pricing information that aligns with their specific research needs.


AGE-RAGE Signaling Pathway in Diabetic Complications
Amyotrophic Lateral Sclerosis